戻る Agenda
Frameworks for Digital Endpoints via the IND Pathway
Session Chair(s)
Megan Doyle, JD, MPH
Associate Vice President, Assistant General Counsel - Diagnostics
Eli Lilly & Company, United States
This panel will discuss current frameworks for digital endpoints that can be used by individual sponsors in their drug development programs, as well as remaining challenges for using digital tools to capture endpoint data.
Learning Objective : Discuss frameworks for digital endpoints that could be used by individual sponsors in their drug development programs; Describe current challenges in using digital tools to capture endpoint data and possible approaches to address this problem.
Speaker(s)
Panelist
Elektra Papadopoulos, MD, MPH
AbbVie, United States
Director, Patient Experience Data and Strategy
Panelist
Lindsay Kehoe, MS
Clinical Trials Transformation Initiative (CTTI), United States
Senior Project Manager, Lead Emerging Programs
Panelist
Andrea Coravos
HumanFirst, United States
Chief Executive Officer
Panelist
Lauren Oliva, PharmD, RPh
Biogen, United States
US Regulatory Policy Lead